|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Medicine (Dr. Johnston), Division of Pulmonary and Critical Care Medicine (Drs. Rubenfeld and Hudson), University of Washington School of Medicine, Harborview Medical Center, Seattle, WA.
Correspondence to: Gordon D. Rubenfeld, MD, MSc, Pulmonary and Critical Care Medicine, Harborview Medical Center, Box 359762, 325 9th Ave, Seattle, WA 98104; e-mail: nodrog{at}u.washington.edu
| Abstract |
|---|
|
|
|---|
Design: Prospective cohort study.
Setting: Level I trauma center.
Measurements and results: A total of 4,020 consecutive trauma patients who were > 12 years of age were identified through the Harborview Medical Center Trauma Registry over a 3-year period. During this time, 484 of the trauma patients (12%) developed ARDS, as identified by the Harborview Medical Center ARDS Registry. Patients who developed ARDS were, on average, older (mean [± SD] age, 44.0 ± 18.8 vs 40.2 ± 20.0 years, respectively; p < 0.0001) and had higher injury severity scores (23.7 ± 11.3 vs 18.0 ± 10.3, respectively; p < 0.0001) than trauma patients who did not develop ARDS. The maximum unadjusted odds ratio for developing ARDS was 2.93 (95% confidence interval, 1.91 to 4.50) for the group 60 to 69 years of age compared to the group 13 to 19 years of age. Patients aged
80 years had an equal risk of developing ARDS compared to those age 13 to 19 years.
Conclusions: Age demonstrated a complex relationship with risk for ARDS development. Older patients showed increasingly higher risks for ARDS development up to 60 to 69 years of age, when the risk for ARDS declined. We concluded that older patients are at significantly greater risk of developing ARDS when compared to younger patients, while the oldest patients may be at less risk.
Key Words: age distribution ARDS epidemiology multiple trauma
| Introduction |
|---|
|
|
|---|
65 years is projected to more than double from 34 million (13% of the current US population) to approximately 70 million (20% of the projected future US population).1
This increase in the number of older persons will be accompanied by an increase in age-related disease, which will have a profound impact on the future of health care and health-care professionals.2
3
4
5
Despite this potential public health crisis, the effect of age on the incidence of many diseases has not been fully characterized. To date, the effect of age on the incidence and risk of ARDS has not been described clearly. Previous studies6 7 8 9 10 have identified several factors that modify or increase the risk of ARDS development in the presence of an underlying high-risk condition such as sepsis, aspiration, and trauma. One factor, severity of illness, as measured by the APACHE II (acute physiology and chronic health evaluation) score or injury severity score (ISS), in patients with a predisposing condition, has been shown to be an independent risk for the development of ARDS.7 Gender,7 chronic alcohol abuse,11 12 and cigarette smoking12 also have been proposed as factors that independently increase the risk for developing ARDS.
Despite the fact that many previous studies have illustrated a clear relationship between increased age and increased mortality13 14 15 16 17 18 19 in patients with ARDS, no studies to date have shown a clear relationship between increased age and the development of ARDS in patients with similar underlying risk conditions. In addition, few studies have prospectively studied risk factors for their association with ARDS using the current definitions most widely used by researchers and clinicians, those developed by the 1994 American-European Consensus Conference (AECC) on ARDS.20
To address these questions, we combined the data from two prospective cohorts to determine the relationship between age and the risk of ARDS in patients with trauma.
| Materials and Methods |
|---|
|
|
|---|
Study Population
From January 1996 to January 1999, 4,020 consecutive patients who were > 12 years of age and had trauma as a principal hospital admission diagnosis were identified at Harborview Medical Center, a county teaching hospital of the University of Washington School of Medicine and a level I trauma center serving four northwestern states that is located in Seattle, WA. During the same 36-month period, 484 trauma patients were identified as having ARDS through the ARDS Registry. Patients
12 years of age were transferred to a childrens hospital during this time period and therefore were not followed by either registry.
Criteria for Diagnosis of ARDS
All patients were followed for their entire hospital course. Patients were considered to have developed ARDS if they met the following 1994 AECC definition20
: PaO2/fraction of inspired oxygen ratio of
200 mm Hg; bilateral pulmonary infiltrates consistent with pulmonary edema; pulmonary artery occlusion pressure of
18 mm Hg when measured; or, in the absence of a pulmonary artery catheter, no clinical evidence of left atrial hypertension.
Variables
The outcome variable for this analysis was the development of ARDS. The exposure variable was age, which was coded as a continuous variable and by decade. Possible confounding variables were those considered to be, or found to be on bivariate analysis, associated with both age and the development of ARDS. On the basis of a review of previously published analyses, we determined that severity of injury, as reflected by the ISS and abbreviated injury scale (AIS), would be included in the analysis.6
7
8
9
Statistical Analysis
Univariate comparisons between trauma patients who developed ARDS and those who did not were evaluated with the
2 test or the independent samples t test, and 95% confidence intervals (CIs) were determined on all odds ratio (OR) calculations. For the confounding variables, ISS and AIS, we compared the mean differences using the independent samples t test.
We considered the following several different ways to code the age variable: as a continuous variable; by decade; and as a dichotomous variable (ie, < 65 vs
65 years of age). Each has advantages and disadvantages, which are presented in the analysis. To identify the crude effect of age, we used a logistic regression model with ARDS development as the dependent variable and age coded as the independent variable.
To identify the effect of age independent of injury severity, we constructed hierarchical multivariate logistic regression models, which included age in decades, and then added ISS, AIS, and the two-way interaction terms age x ISS, age squared, and ISS squared. Variables were left in the model if the p value for the coefficient was < 0.05. All statistical analysis was performed with a statistical software package (SPSS, version 9.0; SPSS, Inc; Chicago, IL).
| Results |
|---|
|
|
|---|
|
|
|
65 years or < 65 years) was not statistically significantly associated with ARDS (OR, 1.23; 95% CI, 0.96 to 1.58). However, when age was broken down into decades, with the group of patients who were 13 to 19 years of age as a reference category, patients aged 30 through 79 years all exhibited statistically significant ORs for ARDS development. Figure 1
illustrates the unadjusted ORs for the development of ARDS and the trend with increasing age by decades. ORs ranged from 1.87 (95% CI, 1.28 to 2.71) in the group 30 to 39 years of age up to 2.93 (95% CI, 1.91 to 4.50) for the group 60 to 69 years of age. Risk then declined in the group 70 to 79 years of age (OR, 2.45; 95% CI, 1.55 to 3.87), and further declined in the group
80 years of age (OR, 1.16 [not statistically significant]; 95% CI, 0.65 to 2.06).
|
|
|
| Discussion |
|---|
|
|
|---|
70 years of age). This peak may be explained by a couple of previously implicated ARDS risk modifiers (ie, fluid management22
and the number of blood transfusions6
). Additional blood products is one possible mechanism whereby physicians may be less likely to tolerate low hematocrit levels and more likely to transfuse older patients. Although not evaluated in our study, it is possible that older patients are at greater risk of developing ARDS because, even after controlling for injury severity, they receive more fluids or blood products. In contrast to the peak in risk, the apparent decline in the risk of ARDS development in the oldest patients may be due to the interplay between age as a risk factor for ARDS and age as a risk factor for death after trauma. In the oldest patient population, patients may die from their underlying trauma or age-biased care before they have a chance to develop ARDS. Alternatively, patients in the oldest patient group may actually be at a lower risk of developing ARDS due to biological differences that occur in the elderly.
Previous studies22 23 have illustrated the existence of age-biased care, in which, compared to similar younger patients, seriously ill older patients receive fewer invasive procedures and hospital care that is less resource-intensive and less costly. Therefore, the oldest trauma patients may not be admitted to the ICU where their lung injury would be diagnosed or may receive less aggressive treatment in the field or emergency department so that they died before they developed ARDS.
It is also possible that the oldest trauma patients are so frail that, regardless of the aggressiveness of their treatment, they die of other injuries before they develop ARDS. However, further analysis of our data revealed that of all the patients who died while in the hospital, those
80 years of age survived for an average of 7.4 days, while the average time to ARDS diagnosis in the same age group was only 4.9 days. Therefore, older patients, on average, appear to survive long enough to develop ARDS before they die from their injuries.
Furthermore, changing immunologic responses with age may add a biological explanation for the observed decline in risk. Those patients that live to be > 70 or 80 years of age prior to their trauma arguably could have genetically protective mechanisms against ARDS development such as the following: a genetic lack of coagulation abnormalities, in which microvascular thromboemboli have been described as playing a role in the injury that occurs to lung vessels in ARDS24 ; or a genetically favorable control of apoptosis pathways, in which it has been illustrated that elevated levels of FAS ligands in the alveoli of ARDS patients may help to increase apoptosis and may lead to lung injury.25 26
Study Limitations
There are several limitations to our study. It is possible that some other confounding variable accounts for the observed association between age and mortality. We were unable to address the influence of several potential confounders, including APACHE II scores and preexisting medical conditions, due to a lack of sufficiently detailed information on these variables in our data set. However, some investigators believe that anatomic injury scoring (eg, the ISS used in our study) is a superior risk adjustor to APACHE in the trauma population.27
In addition, we were unable to control for comorbid diseases, including tobacco and alcohol abuse, that have been associated with ARDS.12
Furthermore, despite utilizing the current accepted diagnostic criteria for ARDS and relying on prospective screening,20
it is possible that some older patients are at greater risk of cardiogenic edema than of noncardiogenic edema, and our observations are limited by our inability to exclude cardiogenic pulmonary edema in all older patients by invasive or noninvasive diagnostic techniques. However, neither the most recent ARDS multicenter clinical trial28
nor the most recent ARDS epidemiologic studies29
30
required specific diagnostic measures to exclude left atrial hypertension. In these studies, as in our study cohort, the assessment was left to bedside clinical discretion in accordance with the AECC ARDS definition,20
and the current diagnostic and research standards. Finally, our study took place in a single level I trauma center. Although patients were drawn from a variety of ethnic groups, socioeconomic backgrounds, and geographic regions, we cannot determine whether our results are generalizable to the community hospital setting.
| Conclusion |
|---|
|
|
|---|
| Footnotes |
|---|
Presented in part at the American Thoracic Society 96th International Conference, May 5 to 10, 2000, Toronto, ON, Canada.
Supported in part by a National Medical Student Research Scholarship from the American Federation for Aging Research and The John A. Hartford Foundation, and by National Institutes of Health Specialized Center of Research in Acute Lung Injury grant HL30542.
Received for publication September 23, 2002. Accepted for publication January 10, 2003.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Salim, M. Martin, C. Constantinou, B. Sangthong, C. Brown, G. Kasotakis, D. Demetriades, and H. Belzberg Acute Respiratory Distress Syndrome in the Trauma Intensive Care Unit: Morbid but Not Mortal Arch Surg, July 1, 2006; 141(7): 655 - 658. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |